Working... Menu

Effect of IL-4RαR576 Polymorphism on Response to Dupilumab in Adolescents and Adults With Asthma (I-DAG)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03694158
Recruitment Status : Not yet recruiting
First Posted : October 3, 2018
Last Update Posted : May 2, 2019
Information provided by (Responsible Party):
Wanda Phipatanakul, Boston Children’s Hospital